Skip to main content

Cel Sci Corp

CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000725363

In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Cel Sci Corp changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CVM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders66562+1
Shares5.97M58.9K6.88M+967.1K (+16.3%)
Value$6.32M$62.5K$2.75M−$3.51M (−56.0%)

5 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Cel Sci Corp at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CVM in Q4 2024
InstitutionSharesValue% of portfolio
Sabby Management, LLC711,735$284.6K2.32%
MAI Capital Management159,600$63.8K0.00%
Gsa Capital Partners LLP45,745$18.0K0.00%
Raymond James Financial Inc40,346$16.1K0.00%
Warberg Asset Management LLC27,560$11.0K0.00%
Providence Wealth Advisors, LLC20,330$8.33K0.01%
HRT Financial LP18,308$7.00K0.00%
AE Wealth Management LLC12,856$5.14K0.00%
SBI Securities Co., Ltd.212$850.00%
Golden State Wealth Management, LLC100$400.00%
UMA Financial Services, Inc.100$400.00%

Sold out (10)

Institutions that held Cel Sci Corp at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CVM in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Calton & Associates, Inc.47,140$50.0K
Price T Rowe Associates Inc26,800$29.0K
Citadel Advisors LLC27,220$28.9K
Commonwealth Equity Services, LLC18,651$20.0K
Dimensional Fund Advisors LP16,484$17.5K
Charles Schwab Investment Management Inc16,481$17.5K
Two Sigma Securities, LLC14,960$15.9K
Jane Street Group, LLC10,465$11.1K
Costello Asset Management, INC3,100$3.29K
Simplex Trading, LLC1,002$1.00K

Not filed for Q4 2024 yet (5)

Institutions that held Cel Sci Corp at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CVM in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James Financial Services Advisors, Inc.22,444$23.8K
Raymond James & Associates18,878$20.0K
Hyperion Partners, LLC16,600$17.6K
Annapolis Financial Services, LLC978$1.04K
BBJS Financial Advisors, LLC40$43